Insulin-like growth factor binding protein-4 (IGFBP-4) tumor and serum levels are increased across all stages of epithelial ovarian cancer
Rebecca Mosig, John A. Martignetti(Cancer Clinic), Robert Fruscio(Azienda Ospedaliera San Gerardo), Mollie Lobl(Albert Einstein College of Medicine), Sergio Marchini(IRCCS Humanitas Research Hospital), Peter R. Dottino(Icahn School of Medicine at Mount Sinai), Ravi Sachidanandam(Icahn School of Medicine at Mount Sinai), Eugene Chudin(Illumina (United States)), Samantha Cohen(Icahn School of Medicine at Mount Sinai), Maurizio D’Incalci(Humanitas University)
Cited by 2
Related Papers
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
|Gastroenterology|2008|729